Blood Glucose Monitoring
The goal of the program is to evaluate and determine the variability among blood glucose monitoring systems and to develop a standardization program to improve and normalize results among these systems.
More Information
C-peptide Standardization Program
Clinical trials of agents to preserve beta cell function in new onset type 1 diabetes will use C-peptide as an outcome measure that indicates insulin production. The C-peptide standardization program is supported to establish reliability in results and facilitate the conduct of international clinical trials.
More Information
Diabetes Autoantibody Standardization Program (DASP)
The fundamental aim of DASP is to improve the measurements of the autoantibodies predictive of type 1 diabetes.
More Information
Improving the Clinical Measurement of HbA1C
The goal of this project is to improve HbA1c measurements and data interpretation across clinical systems and national harmonization projects.
More Information
Return to Research Consortia and Clinical Trials Networks Topic List